National Academies Press: OpenBook

Issues in Risk Assessment (1993)

Chapter: SCOPE OF REPORT

« Previous: BACKGROUND
Suggested Citation:"SCOPE OF REPORT." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×

induce cancer through mechanisms that do not occur at lower doses, thereby generating false-positive inferences of hazard and risk for humans who are exposed at lower doses. The committee was given pharmacokinetic and other mechanistic arguments, such as induced cell proliferation, that support this hypothesis.

  • Even in cases where effects might occur as a result of low dose exposure, the results of an MTD test might have little utility in defining the dose-response relationship. Some agents could have nonlinear dose-response relationships that reflect pharmacokinetics, induced cell proliferation, or other mechanisms. The result of the nonlinearity could be overestimation (or, in some cases, underestimation) of low dose risks. Overestimation could occur where the dose-response curve has a shallow slope at low doses and becomes markedly steeper at higher doses. Underestimation could occur where the dose-response curve flattens out or curves downward at high doses.

  • Statistical analysis of bioassay results for many agents has shown strong correlations between estimates of carcinogenic potency and measures of toxicity (including the MTD) that suggest that carcinogenicity is inherently related in some way to other toxic effects produced by a chemical. However, some investigators have concluded that those correlations, and possibly estimates of carcinogenic potency, are determined in some way by the bioassay design or the mathematical and statistical methods used to estimate potency and investigate the correlations, rather than by inherent biologic properties of the agents.

SCOPE OF REPORT

The above points are all addressed in various degrees in this report. Particular attention is focused (in Chapter 2) on the fourth point—questions concerning the observed correlations between measures of carcinogenic potency and the MTD. The report explores the extent to which the correlations appear to reflect some underlying biologic reality, as opposed to being determined solely by experimental design or statistical methods. It further considers the relationship of the correlations to possible biologic mechanisms of carcinogenesis and the implications of the correlations for risk assessment.

The report discusses both what bioassays conducted at the MTD can

Suggested Citation:"SCOPE OF REPORT." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×

tell us and what they cannot tell us, qualitatively and quantitatively, regarding carcinogenic hazard in humans (Chapter 3). Several proposals are discussed (Chapter 4) for modifying the design of the bioassay, for modifying the process of selecting chemicals for testing, and for augmenting the results of the bioassay with additional testing to improve risk assessments.

The committee's conclusions are presented in Chapter 5 with the recommendations of the majority of the committee concerning the better use of bioassays, specific results from bioassays, and other types of data to assess carcinogenic hazards in human populations. The dissenting recommendations of a minority of the committee are also described.

An active discussion is in progress in the scientific community concerning the extent to which high doses produce increased mitogenesis (cell division) and how much the increase contributes to the incidence of cancer at the MTD and lower doses. That was the subject of a presentation given at the MTD workshop conducted by the committee (see the summary of the workshop at the end of the report). This report reviews and evaluates the recent research related to the issue.

Although the MTD concept is used in other contexts (e.g., tests for reproductive toxicity and teratogenicity), the committee essentially limited its investigation to the use of the MTD in bioassays for carcinogenicity associated with exposure to chemicals.

Suggested Citation:"SCOPE OF REPORT." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
This page in the original is blank.
Suggested Citation:"SCOPE OF REPORT." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
Page 18
Suggested Citation:"SCOPE OF REPORT." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
Page 19
Suggested Citation:"SCOPE OF REPORT." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
Page 20
Next: DEFINITIONS AND BACKGROUND »
Issues in Risk Assessment Get This Book
×
Buy Paperback | $65.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The scientific basis, inference assumptions, regulatory uses, and research needs in risk assessment are considered in this two-part volume.

The first part, Use of Maximum Tolerated Dose in Animal Bioassays for Carcinogenicity, focuses on whether the maximum tolerated dose should continue to be used in carcinogenesis bioassays. The committee considers several options for modifying current bioassay procedures.

The second part, Two-Stage Models of Carcinogenesis, stems from efforts to identify improved means of cancer risk assessment that have resulted in the development of a mathematical dose-response model based on a paradigm for the biologic phenomena thought to be associated with carcinogenesis.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!